Developing mouse models of diffuse large B cell lymphoma for therapeutic discovery

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Diffuse large B cell lymphomas are aggressive cancers of white blood cells. Gene mutations play significant yet poorly understood roles in the cause of these lymphomas and their resistance to drug treatments. I plan to develop new mouse models of lymphoma to identify factors that cause lymphoma to develop in living organisms and factors that cause them to resist drug treatment. I will also test if combinations of multiple drugs can effectively and safely treat these lymphomas.

Funded Activity Details

Start Date: 01-01-2018

End Date: 01-01-2022

Funding Scheme: Early Career Fellowships

Funding Amount: $408,768.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Haematological Tumours

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cancer treatment | genetics | lymphoma | mouse models | signalling pathways